Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Erik Schliebs"'
Autor:
Natalia Maier, Monique Butze, Burkhard Micheel, Gabriele Heidicke, Erik Schliebs, Jonas Füner, Katja Hanack, Pamela Holzlöhner, Nicole Hebel
Camelids possess antibodies with a conventional four-chain structure consisting of two heavy and two light chains (of subclass IgG1) but further they also generate heavy-chain only antibodies (of subclass IgG2 and 3) which are fully functional in ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088364cd2960961e7743f84d9ebe2367
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/53444
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/53444
Autor:
Erik Schliebs, Burkhard Micheel, Peter Schierack, Cindy Grieß, Dirk Reinhold, Pamela Holzlöhner, Christian Hentschel, Anja Schlör, Jonas Füner, Alexander Goihl, Monique Butze, Dirk Roggenbuck, Katja Hanack, Mandy Sowa, Martin Listek
Publikováno v:
New biotechnology. 45
Pancreatic secretory zymogen-granule membrane glycoprotein 2 (GP2) has been identified as a major autoantigenic target in Crohn’s disease patients. It was reported recently that a long (GP2a) and a short (GP2b) isoform of GP2 exist and that in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81b85ca73458b238206c64155c3a825
https://pubmed.ncbi.nlm.nih.gov/29635104
https://pubmed.ncbi.nlm.nih.gov/29635104
Autor:
Katja Hanack, Anja Schlör, Pamela Holzlöhner, Martin Listek, Cindy Bauer, Monique Butze, Burkhard Micheel, Christian Hentschel, Mandy Sowa, Dirk Roggenbuck, Peter Schierack, Jonas Füner, Erik Schliebs, Alexander Goihl, Dirk Reinhold
Publikováno v:
The Journal of Immunology. 196:209.8-209.8
Pancreatic secretory zymogen-granule membrane glycoprotein 2 (GP2) has been identified to be a major autoantigenic target in Crohn’s disease patients. It was discussed recently that a long and a short isoform of GP2 exists whereas the short isoform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c112a12fce68cffdf64cc355bdcbd5ec
https://doi.org/10.4049/jimmunol.196.supp.209.8
https://doi.org/10.4049/jimmunol.196.supp.209.8
Development of detection tools for health monitoring in new world and old world camelid (TECH2P.762)
Autor:
Pamela Holzloehner, Erik Schliebs, Natalia Maier, Friederike Naumann, Jonas Füner, Burkhard Micheel, Katja Hanack
Publikováno v:
The Journal of Immunology. 194:206.8-206.8
Keeping and breeding of new and old world camelids in Europe is a very complex process influenced by altered climate conditions in comparison to the natural habitat in desert ecosystems. Especially the veterinary care for these animals is lacking spe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6aa22b9d90e256cdfecedc362ceedae5
https://doi.org/10.4049/jimmunol.194.supp.206.8
https://doi.org/10.4049/jimmunol.194.supp.206.8
Autor:
Pamela Holzloehner, Erik Schliebs, Natalia Maier, Jonas Füner, Burkhard Micheel, Katja Heilmann
Publikováno v:
The Journal of Immunology. 190:135.14-135.14
Here we describe the first monoclonal immunoglobulins produced by camelid hybridomas. Hybridomas were generated by using the CBF7 heteromyeloma line to fuse peripheral blood lymphocytes from New World camels (llamas, alpacas) and Old World camels (Ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::109d7925ed047b3811db0626646f7d7d
https://doi.org/10.4049/jimmunol.190.supp.135.14
https://doi.org/10.4049/jimmunol.190.supp.135.14
Autor:
Pamela Holzlöhner, Erik Schliebs, Natalia Maier, Friederike Pfister, Jonas Füner, Burkhard Micheel, Katja Heilmann
Publikováno v:
The Journal of Immunology. 186:65.11-65.11
Camelid antibodies are of special interest because some of them belong to immunoglobulin subclasses (IgG2 and IgG3) which are build up only by heavy chains. To use such antibodies for practical application we need specific identification tools. Immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a19dd0c42fc434561890ca801f867e8
https://doi.org/10.4049/jimmunol.186.supp.65.11
https://doi.org/10.4049/jimmunol.186.supp.65.11